Top Banner

of 3

L1 Subtype of Acute Lymphocytic Leukemia ALL

Apr 06, 2018

Download

Documents

Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
  • 8/3/2019 L1 Subtype of Acute Lymphocytic Leukemia ALL

    1/3

    PREPARED BY:

    MOHD KHAIRUL AMRAN BIN MOHAMMAD

    Bsc. In MEDICAL LABORATORY TECHNOLOGYFACULTY OF HEALTH SCIENCE

    UNIVERSITY TEKNOLOGI MARA UiTM

  • 8/3/2019 L1 Subtype of Acute Lymphocytic Leukemia ALL

    2/3

    p

    Complete blood count

    presence of circulatory leukemic blastcells.

    The presence and severity of anemia. The count of a variety of blood cell types. Thrombocytopenia

    Peripheral blood smear

    Precursor B-cell lymphoblastic leukemia

    Blasts are heterogeneous in size, haveround or convoluted nuclei, have a high

    nuclear/cytoplasmic ratio, and lack

    cytoplasmic granules.ATL

    Leukemia cells are typical CD4+ cellswith cloven hoof or flower-shaped

    nuclei.

    Burkitts leukemia

    Typical monotonous mass of medium-sized cells with round nuclei, multiple

    nucleoli, and basophilic cytoplasm with

    cytoplasmic vacuoles

    Imaging

    Not indicated

    Diagnostic procedures

    Bone marrow biopsy with geneticand immunologic studies

    o Diagnosis of ALL requires 30%lymphoblasts in the bonemarrow.

    Lumbar puncture, to rule out occultCNS involvement

    Classification

    French-American-British (FAB)

    classification for ALL

    Immunologic subtype: preB-cellALL

    Immunologic subtype: T-cell ALL Immunolo ic subt e: B-cell ALL

    Treatment

    Intensive induction phaseo Usually a combination

    ofvincristine, prednisone, an

    anthracycline andcytarabine,

    usually with L-asparaginase CNS prophylaxis Maintenance chemotherapy that

    extends for about 2 years

    Long-term survival of 6575% ofpatients may be achieved.

    Philadelphia chromosomepositiveALL management includes imatinib.

    Bone marrow transplantation

    ACUTE LYMPHOCYTIC LEUKEMIA, ALL

    Description

    A progressive cancer of immaturelymphocytes, with primary

    involvement of bone marrow and

    blood.

    Acute lymphoid leukemias (ALLs)include:

    o Precursor lymphoblastic leukemia(20% B cell, 80% T cell)

    o Burkitts leukemia(100% B cell)o Adult T-cell

    leukemia/lymphoma (ATL) (100%

    T cell)

    Lymphoblastic lymphoma, a cancerinvolving bone marrow and causing a

    mediastinal mass, is related to T-cell

    ALL.

    Sign and symptoms

    Fever Anemia Bleeding and/or bruishing Persistent weakness or tireness Achiness in the bones or joins Recurrent infections Difficulty breathing or swollen lymph

    nodes

    http://www.harrisonspractice.com/practice/ub/view/DrugMonographs/156708/0/vincristinehttp://www.harrisonspractice.com/practice/ub/view/DrugMonographs/156368/0/prednisonehttp://www.harrisonspractice.com/practice/ub/view/DrugMonographs/155444/0/cytarabinehttp://www.harrisonspractice.com/practice/ub/view/DrugMonographs/155851/0/imatinibhttp://www.harrisonspractice.com/practice/ub/view/Harrisons%20Practice/141555/0/Bone_marrow_transplantationhttp://www.harrisonspractice.com/practice/ub/view/Harrisons%20Practice/141547/0/Burkitt%C2%92s_leukemiahttp://www.harrisonspractice.com/practice/ub/view/Harrisons%20Practice/141547/0/Burkitt%C2%92s_leukemiahttp://www.harrisonspractice.com/practice/ub/view/Harrisons%20Practice/141548/0/Adult_T_cell_leukemia_lymphomahttp://www.harrisonspractice.com/practice/ub/view/Harrisons%20Practice/141548/0/Adult_T_cell_leukemia_lymphomahttp://www.harrisonspractice.com/practice/ub/view/Harrisons%20Practice/141548/0/Adult_T_cell_leukemia_lymphomahttp://www.harrisonspractice.com/practice/ub/view/Harrisons%20Practice/141548/0/Adult_T_cell_leukemia_lymphomahttp://www.harrisonspractice.com/practice/ub/view/Harrisons%20Practice/141547/0/Burkitt%C2%92s_leukemiahttp://www.harrisonspractice.com/practice/ub/view/Harrisons%20Practice/141555/0/Bone_marrow_transplantationhttp://www.harrisonspractice.com/practice/ub/view/DrugMonographs/155851/0/imatinibhttp://www.harrisonspractice.com/practice/ub/view/DrugMonographs/155444/0/cytarabinehttp://www.harrisonspractice.com/practice/ub/view/DrugMonographs/156368/0/prednisonehttp://www.harrisonspractice.com/practice/ub/view/DrugMonographs/156708/0/vincristine
  • 8/3/2019 L1 Subtype of Acute Lymphocytic Leukemia ALL

    3/3

    Cytologic features

    Cell size small cell predominate Nuclear chromatin homogenous Nuclear shape regular Nucleoli not visible or small and

    inconspicuous

    Amount of cytoplasm scanty Basophilia of cytoplasm slightly or

    moderate, rarely intense

    Cytoplasmic vacuolation - variable

    Impression:

    Acute lymphocytic leukemia subtype L1

    L2 subtype of ALL

    Impression:

    Acute lymphocytic leukemia subtype L2

    Cytologic features

    Cell size large, heterogenous in size Nuclear chromatin heterogenous Nuclear shape irregular, clefting and

    indentation common.

    Nucleoli one or more present, oftenlarge

    Amount of cytoplasm variable, oftenmoderately abundant

    Basophilia of cytoplasm variable, deepin some

    Cytoplasmic vacuolation - variable

    L3 subtype of ALL

    Impression:

    Acute lymphocytic leukemia subtype L3

    Cytologic features

    Cell size large, heterogenous in size Nuclear chromatin finely slippled and

    homogenous

    Nuclear shape regular, oval to round Nucleoli prominent, one or more

    vesicular

    Amount of cytoplasm moderatelyabundant

    Basophilia of cytoplasm very deep Cytoplasmic vacuolation often

    prominent

    L1 subtype of ALL